Bank of America
GMAB icon

Bank of America’s Genmab GMAB Stock Holding History

Bank of America’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.12M Buy
259,249
+17,729
+7% +$471K ﹤0.01% 3280
2026
Q1 		$6.48M Sell
241,520
-98,397
-29% -$2.95M ﹤0.01% 3272
2025
Q4 		$10.5M Buy
339,917
+11,827
+4% +$369K ﹤0.01% 2816
2025
Q3 		$10.1M Sell
328,090
-239,705
-42% -$5.84M ﹤0.01% 3302
2025
Q2 		$11.7M Sell
567,795
-115,253
-17% -$2.37M ﹤0.01% 3091
2025
Q1 		$13.4M Buy
683,048
+208,190
+44% +$4.37M ﹤0.01% 2855
2024
Q4 		$9.91M Sell
474,858
-579,588
-55% -$12.7M ﹤0.01% 2945
2024
Q3 		$25.7M Sell
1,054,446
-42,825
-4% -$1.14M ﹤0.01% 2166
2024
Q2 		$27.6M Buy
1,097,271
+14,724
+1% +$417K ﹤0.01% 1941
2024
Q1 		$32.4M Buy
1,082,547
+193,383
+22% +$5.68M ﹤0.01% 1837
2023
Q4 		$28.3M Sell
889,164
-23,123
-3% -$726K ﹤0.01% 1821
2023
Q3 		$32.2M Buy
912,287
+15,691
+2% +$598K ﹤0.01% 1599
2023
Q2 		$34.1M Sell
896,596
-98,477
-10% -$3.93M ﹤0.01% 1596
2023
Q1 		$37.6M Buy
995,073
+91,462
+10% +$3.52M ﹤0.01% 1583
2022
Q4 		$38.3M Buy
903,611
+120,160
+15% +$4.95M ﹤0.01% 1490
2022
Q3 		$25.2M Sell
783,451
-28,124
-3% -$988K ﹤0.01% 1766
2022
Q2 		$26.4M Sell
811,575
-38,545
-5% -$1.25M ﹤0.01% 1772
2022
Q1 		$30.8M Sell
850,120
-11,121
-1% -$382K ﹤0.01% 1748
2021
Q4 		$34.1M Sell
861,241
-266,421
-24% -$11.1M ﹤0.01% 1727
2021
Q3 		$49.3M Buy
1,127,662
+38,936
+4% +$1.75M 0.01% 1366
2021
Q2 		$44.5M Buy
1,088,726
+222,776
+26% +$8.6M ﹤0.01% 1449
2021
Q1 		$28.4M Sell
865,950
-93,514
-10% -$3.52M ﹤0.01% 1730
2020
Q4 		$39M Buy
959,464
+118,512
+14% +$4.43M 0.01% 1358
2020
Q3 		$30.8M Buy
840,952
+167,135
+25% +$6.04M ﹤0.01% 1380
2020
Q2 		$22.8M Sell
673,817
-442,603
-40% -$12.1M ﹤0.01% 1524
2020
Q1 		$23.7M Sell
1,116,420
-11,840
-1% -$264K ﹤0.01% 1387
2019
Q4 		$25.2M Buy
1,128,260
+196,379
+21% +$4.29M ﹤0.01% 1698
2019
Q3 		$18.9M Buy
+931,881
New +$18.4M ﹤0.01% 1879

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Bank of America's GMAB Position: Q2 2026 in Review

Bank of America increased its Genmab (GMAB) stake by 7.3% in Q2 2026, buying an estimated $471K and bringing the position to 259,249 shares worth $7.12M. The position accounts for ﹤0.01% of the portfolio, ranked #3280.

Bank of America first reported a position in GMAB in Q3 2019 and has held it in 28 quarters since. The position peaked at $49.3M in Q3 2021. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Bank of America held 259,249 shares of Genmab worth $7.12M as of Q2 2026.
  • Bank of America bought 17,729 Genmab shares in Q2 2026, an estimated $471K.
  • Genmab made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #3280 holding.
  • Bank of America first reported a position in Genmab in Q3 2019 and has held it in 28 quarters since.
  • Bank of America's Genmab position peaked at $49.3M in Q3 2021.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.